We are engaged in on-going collection of data regarding the phenotypic and genotypic spectrum of patients with variants in ASNA1. Further studies focusing on the underlying molecular mechanisms and therapeutic options are being developed.
If you would like to receive additional information, please contact j.m.a.verhagen@erasmusmc.nl or i.vandelaar@erasmusmc.nl